Invitae Corporation Operating Expenses 2011-2026 | NVTA

Annual Operating Expenses Invitae Corporation

2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	343 M	190 M	139 M	97.4 M	81.3 M	43.3 M	24.2 M	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
343 M	24.2 M	131 M

Operating Expenses of other stocks in the Diagnostics research industry

Issuer	Operating Expenses	Price	% 24h	Market Cap	Country
Enzo Biochem ENZ	47.4 M	-	-8.98 %	$ 14.8 K	USA
Centogene N.V. CNTG	58 M	-	-6.23 %	$ 30.6 M	Germany
Heska Corporation HSKA	131 M	-	-	$ 1.31 B	USA
Celcuity CELC	172 M	$ 88.28	-4.53 %	$ 4.13 B	USA
Akumin AKU	778 M	-	-17.87 %	$ 25.9 M	Canada
Co-Diagnostics CODX	50.6 M	$ 5.63	-2.26 %	$ 7.49 M	USA
Castle Biosciences CSTL	59.5 M	$ 21.01	-2.73 %	$ 609 M	USA
Fulgent Genetics FLGT	222 M	$ 19.15	-1.79 %	$ 589 M	USA
Aspira Women's Health AWH	13.8 M	-	-6.19 %	$ 10.5 M	USA
Accelerate Diagnostics AXDX	77.2 M	-	-61.36 %	$ 2.46 M	USA
Guardant Health GH	226 M	$ 125.61	-5.6 %	$ 15.7 B	USA
Biocept BIOC	21.6 M	-	-13.05 %	$ 7.29 M	USA
Interpace Biosciences IDXG	20 M	$ 1.67	-6.7 %	$ 7.39 M	USA
Oxford Immunotec Global PLC OXFD	59.4 M	-	-	$ 562 M	Britain
Illumina ILMN	2.06 B	$ 162.32	-3.42 %	$ 25.2 B	USA
CareDx, Inc CDNA	411 M	$ 22.25	-3.76 %	$ 1.19 B	USA
Chembio Diagnostics CEMI	28.5 M	-	0.22 %	$ 16.8 M	USA
Check-Cap Ltd. CHEK	14.1 M	-	-	$ 9.42 M	Israel
ICON Public Limited Company ICLR	408 M	$ 149.45	-2.19 %	$ 11.7 B	Irlanda
HTG Molecular Diagnostics HTGM	24.1 M	-	-20.0 %	$ 1.06 M	USA
Lantheus Holdings LNTH	123 M	$ 100.98	-1.79 %	$ 6.82 B	USA
Global Cord Blood Corporation CO	451 M	-	-	$ 399 M	China
Fluidigm Corporation FLDM	134 M	-	1.08 %	$ 308 M	USA
Genetic Technologies Limited GENE	5.91 M	-	-	$ 7.1 B	Australia
Genetron Holdings Limited GTH	983 M	-	0.12 %	$ 80.1 M	China
DermTech DMTK	104 M	-	-11.32 %	$ 2.94 M	USA
NeoGenomics NEO	430 M	$ 10.9	-3.63 %	$ 1.4 B	USA
Natera NTRA	258 M	$ 215.31	-3.06 %	$ 29.4 B	USA
Charles River Laboratories International CRL	607 M	$ 181.34	-2.4 %	$ 8.99 B	USA
PRA Health Sciences, Inc. PRAH	585 M	-	-	$ 10.7 B	USA
Pacific Biosciences of California PACB	600 M	$ 1.45	-11.04 %	$ 435 M	USA
Medpace Holdings MEDP	118 M	$ 454.25	-0.97 %	$ 13.1 B	USA
Mettler-Toledo International MTD	1.01 B	$ 1 154.33	-2.22 %	$ 23.8 B	Schweiz
Exact Sciences Corporation EXAS	2.47 B	-	-	$ 19.8 B	USA
Myriad Genetics MYGN	964 M	$ 4.57	-2.56 %	$ 423 M	USA
National Research Corporation NRC	38.5 M	$ 19.14	-3.09 %	$ 428 M	USA
Personalis PSNL	44.5 M	$ 10.75	-11.16 %	$ 959 M	USA
Koninklijke Philips N.V. PHG	7.12 B	$ 26.11	0.46 %	$ 24.8 B	Niderland
Senseonics Holdings SENS	61.8 M	$ 6.67	-4.85 %	$ 278 M	USA
QIAGEN N.V. QGEN	821 M	-	-	$ 10.6 B	Niderland
Soleno Therapeutics SLNO	181 M	-	-	$ 2.69 B	USA
Biomerica BMRA	5.64 M	$ 2.12	-1.17 %	$ 4.87 M	USA
Laboratory Corporation of America Holdings LH	1.87 B	$ 265.15	1.6 %	$ 22.1 B	USA
Twist Bioscience Corporation TWST	116 M	$ 69.22	-6.37 %	$ 4.14 B	USA
Thermo Fisher Scientific TMO	7.15 B	$ 472.8	-1.91 %	$ 178 B	USA
Trinity Biotech plc TRIB	28.3 M	$ 0.67	-2.43 %	$ 241 M	Irlanda
Motus GI Holdings MOTS	19.1 M	-	-34.28 %	$ 263 K	Israel
Waters Corporation WAT	687 M	$ 365.36	-2.95 %	$ 21.8 B	USA
Neogen Corporation NEOG	1.48 B	$ 8.9	-2.41 %	$ 1.93 B	USA
Quest Diagnostics Incorporated DGX	1.46 B	$ 200.29	2.13 %	$ 22.2 B	USA